COHERENT CORP.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows –
Condensed Consolidated Statements of Cash Flows (Unaudited)
($000)
| Three Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash Flows from Operating Activities | ||
| Net earnings | $381,601 | $225,196 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation | 77,665 | 52,983 |
| Amortization | 69,451 | 69,446 |
| Share-based compensation expense | 74,377 | 44,134 |
| Non-cash restructuring and impairment charges | 1,154 | 9,872 |
| Amortization of debt issuance costs | 2,458 | 9,786 |
| Loss on disposals of property, plant & equipment | 1,006 | 127 |
| Unrealized gains on foreign currency remeasurements and transactions | (999) | (4,226) |
| Earnings from equity investments | (211) | (215) |
| Deferred income taxes | (55,657) | (83,665) |
| Gain on sale of business | — | (115,211) |
| Gain on sale of equity investment | — | (6,726) |
| Loss on debt extinguishment | — | 3,056 |
| Increase (decrease) in cash from changes in: | ||
| Accounts receivable | (255,278) | (66,628) |
| Inventories | (737,082) | (219,120) |
| Accounts payable | 429,824 | 105,357 |
| Contract liabilities | 269,276 | (8,022) |
| Income taxes | (32,959) | 37,221 |
| Accrued compensation and benefits | (90,196) | (48,206) |
| Other operating net assets (liabilities) | (227,111) | 40,796 |
| Net cash provided by (used in) operating activities | (92,681) | 45,955 |
| Cash Flows from Investing Activities | ||
| Additions to property, plant & equipment | (775,547) | (103,946) |
| Proceeds from sale of equity investment | — | 9,635 |
| Proceeds from the sale of business, net of fees | — | 391,127 |
| Proceeds from sales/maturities of short-term investments | 625,000 | — |
| Other investing activities | (50,368) | (18) |
| Net cash provided by (used in) investing activities | (200,915) | 296,798 |
| Cash Flows from Financing Activities | ||
| Proceeds from borrowings of Term A Facility | — | 1,250,000 |
| Proceeds from borrowings of Term B Facility | — | 3,267 |
| Proceeds from borrowings of revolving credit facilities | 11,660 | 88,908 |
| Proceeds from borrowings of other credit facilities | 773,355 | — |
| Payments on existing debt | (779) | (1,650,805) |
| Payments on borrowings under revolving credit facilities | (9,835) | (77,046) |
| Debt issuance costs | — | (8,542) |
| Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan | 19,416 | 21,278 |
| Payments in satisfaction of employees’ minimum tax obligations | (128,633) | (37,443) |
| Cash dividends paid | — | (11,438) |
| Other financing activities | (572) | 335 |
| Net cash provided by (used in) financing activities | 664,612 | (421,486) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (3,069) | (1,280) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 367,947 | (80,013) |
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 1,768,396 | 1,632,913 |
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $2,136,343 | $1,552,900 |
| Supplemental Information | ||
|---|---|---|
| Cash paid for interest | $29,398 | $40,996 |
| Cash paid for income taxes | $65,183 | $49,375 |
| Non-Cash Investing and Financing Activities: | ||
| Additions to property, plant & equipment included in accounts payable | $527,734 | $71,647 |
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets that sum to the total of the same amounts shown in the Condensed Consolidated Statements of Cash Flows.
| September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash and cash equivalents | $1,552,929 | $852,778 |
| Restricted cash, current | 44,576 | 22,549 |
| Restricted cash, non-current | 538,838 | 677,573 |
| Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows | $2,136,343 | $1,552,900 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.